Cargando…

Assessment of Anti m-RNA SARS-CoV-2 (BNT162b2) Antibody Titres in Mother and Child Pairs of Breastfeeding Women Vaccinated Post-Delivery

The global response to the COVID-19 pandemic has been successfully driven by efforts to ramp up access to vaccines. Pregnant or breastfeeding women and their children have not benefited from the vaccines despite their susceptibility to the virus. We investigated whether women who were offered vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kociszewska-Najman, Bożena, Jaskólska, Magdalena, Taradaj, Karol, Sibanda, Elopy, Ginda, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323872/
https://www.ncbi.nlm.nih.gov/pubmed/35891253
http://dx.doi.org/10.3390/vaccines10071089
_version_ 1784756664587517952
author Kociszewska-Najman, Bożena
Jaskólska, Magdalena
Taradaj, Karol
Sibanda, Elopy
Ginda, Tomasz
author_facet Kociszewska-Najman, Bożena
Jaskólska, Magdalena
Taradaj, Karol
Sibanda, Elopy
Ginda, Tomasz
author_sort Kociszewska-Najman, Bożena
collection PubMed
description The global response to the COVID-19 pandemic has been successfully driven by efforts to ramp up access to vaccines. Pregnant or breastfeeding women and their children have not benefited from the vaccines despite their susceptibility to the virus. We investigated whether women who were offered vaccination after delivery passively transferred protective antibodies to their infants via breast milk. Serum was collected from breast feeding mother–infant pairs and analysed for levels of antibodies to the SARS-CoV-2 spike protein using the CLIA chemiluminescence technique. Data were analysed for the significance of the differences using the Mann–Whitney U test and the Spearman’s rank correlation coefficient to determine the strength of the correlation. A total of 13 mothers, mean age 34.86 (95%CI = 33.21–36.48) years and their infants, mean age 15.77 (95%CI = 11.24–20.29) months were enrolled. The mothers had completed their courses of the mRNA BNT162b2 SARS-CoV-2 vaccine during breastfeeding, 8.3 (95%CI = 7.24–9.36) months before the study. All 13 mothers had detectable antibodies to the SARS-CoV-2 spike protein, mean 1252, (95%CI = 736–1769) BAU/mL. Antibodies were detected in 3/13 (23%) breast-fed infants mean 322, (95%CI = 252–897) BAU/mL. There was no correlation between the maternal and infant IgG antibody titres. The time-lag since full vaccination did not correlate to the presence of antibodies in infant sera. Maternal or infant ages did not correlate to the presence of antibodies. Although some children (23%) had anti-SARS-CoV-2 antibodies, there was no association between vaccine-induced COVID-19 spike protein specific maternal IgG antibody titres and the presence of antibodies in the breastfed infants. The data show that the transfer of passive immunity to infants following post-partum vaccination with the mRNA BNT162b2 SARS-CoV-2 vaccine may be infrequent in this population.
format Online
Article
Text
id pubmed-9323872
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93238722022-07-27 Assessment of Anti m-RNA SARS-CoV-2 (BNT162b2) Antibody Titres in Mother and Child Pairs of Breastfeeding Women Vaccinated Post-Delivery Kociszewska-Najman, Bożena Jaskólska, Magdalena Taradaj, Karol Sibanda, Elopy Ginda, Tomasz Vaccines (Basel) Article The global response to the COVID-19 pandemic has been successfully driven by efforts to ramp up access to vaccines. Pregnant or breastfeeding women and their children have not benefited from the vaccines despite their susceptibility to the virus. We investigated whether women who were offered vaccination after delivery passively transferred protective antibodies to their infants via breast milk. Serum was collected from breast feeding mother–infant pairs and analysed for levels of antibodies to the SARS-CoV-2 spike protein using the CLIA chemiluminescence technique. Data were analysed for the significance of the differences using the Mann–Whitney U test and the Spearman’s rank correlation coefficient to determine the strength of the correlation. A total of 13 mothers, mean age 34.86 (95%CI = 33.21–36.48) years and their infants, mean age 15.77 (95%CI = 11.24–20.29) months were enrolled. The mothers had completed their courses of the mRNA BNT162b2 SARS-CoV-2 vaccine during breastfeeding, 8.3 (95%CI = 7.24–9.36) months before the study. All 13 mothers had detectable antibodies to the SARS-CoV-2 spike protein, mean 1252, (95%CI = 736–1769) BAU/mL. Antibodies were detected in 3/13 (23%) breast-fed infants mean 322, (95%CI = 252–897) BAU/mL. There was no correlation between the maternal and infant IgG antibody titres. The time-lag since full vaccination did not correlate to the presence of antibodies in infant sera. Maternal or infant ages did not correlate to the presence of antibodies. Although some children (23%) had anti-SARS-CoV-2 antibodies, there was no association between vaccine-induced COVID-19 spike protein specific maternal IgG antibody titres and the presence of antibodies in the breastfed infants. The data show that the transfer of passive immunity to infants following post-partum vaccination with the mRNA BNT162b2 SARS-CoV-2 vaccine may be infrequent in this population. MDPI 2022-07-07 /pmc/articles/PMC9323872/ /pubmed/35891253 http://dx.doi.org/10.3390/vaccines10071089 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kociszewska-Najman, Bożena
Jaskólska, Magdalena
Taradaj, Karol
Sibanda, Elopy
Ginda, Tomasz
Assessment of Anti m-RNA SARS-CoV-2 (BNT162b2) Antibody Titres in Mother and Child Pairs of Breastfeeding Women Vaccinated Post-Delivery
title Assessment of Anti m-RNA SARS-CoV-2 (BNT162b2) Antibody Titres in Mother and Child Pairs of Breastfeeding Women Vaccinated Post-Delivery
title_full Assessment of Anti m-RNA SARS-CoV-2 (BNT162b2) Antibody Titres in Mother and Child Pairs of Breastfeeding Women Vaccinated Post-Delivery
title_fullStr Assessment of Anti m-RNA SARS-CoV-2 (BNT162b2) Antibody Titres in Mother and Child Pairs of Breastfeeding Women Vaccinated Post-Delivery
title_full_unstemmed Assessment of Anti m-RNA SARS-CoV-2 (BNT162b2) Antibody Titres in Mother and Child Pairs of Breastfeeding Women Vaccinated Post-Delivery
title_short Assessment of Anti m-RNA SARS-CoV-2 (BNT162b2) Antibody Titres in Mother and Child Pairs of Breastfeeding Women Vaccinated Post-Delivery
title_sort assessment of anti m-rna sars-cov-2 (bnt162b2) antibody titres in mother and child pairs of breastfeeding women vaccinated post-delivery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323872/
https://www.ncbi.nlm.nih.gov/pubmed/35891253
http://dx.doi.org/10.3390/vaccines10071089
work_keys_str_mv AT kociszewskanajmanbozena assessmentofantimrnasarscov2bnt162b2antibodytitresinmotherandchildpairsofbreastfeedingwomenvaccinatedpostdelivery
AT jaskolskamagdalena assessmentofantimrnasarscov2bnt162b2antibodytitresinmotherandchildpairsofbreastfeedingwomenvaccinatedpostdelivery
AT taradajkarol assessmentofantimrnasarscov2bnt162b2antibodytitresinmotherandchildpairsofbreastfeedingwomenvaccinatedpostdelivery
AT sibandaelopy assessmentofantimrnasarscov2bnt162b2antibodytitresinmotherandchildpairsofbreastfeedingwomenvaccinatedpostdelivery
AT gindatomasz assessmentofantimrnasarscov2bnt162b2antibodytitresinmotherandchildpairsofbreastfeedingwomenvaccinatedpostdelivery